Linking market authorizations of medicines with disease burden in South Africa
Background Sub-Saharan Africa is going through an epidemiological transition, including an impressive increase in non-communicable diseases. The introduction of medicines has not kept pace with the needs in developing countries. The objectives of this study were to (i) examine the correlation betwee...
Saved in:
Main Authors: | K. Narsai (Author), H. G. M. Leufkens (Author), A. K. Mantel-Teeuwisse (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2021-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Outer packaging labelling of medicines in Southern African Development Community (SADC) countries: comparative analysis of requirements and transition terms for harmonisation
by: K. Narsai, et al.
Published: (2024) -
Variability in market uptake of psychotropic medications in Europe reflects cultural diversity
by: J. M. Hoebert, et al.
Published: (2017) -
The caregiver's experience of childhood cancer treatment in South Africa
by: I. R. Joosse, et al.
Published: (2024) -
Access to childhood cancer medicines in South Africa: a health systems analysis of barriers and enablers
by: Iris R. Joosse, et al.
Published: (2024) -
Medicine shortages: impact behind numbers
by: Doerine J. Postma, et al.
Published: (2023)